GlassScriptPhysician profile
Lori A Repp
NPI 1982817953
$1,440.21
in general payments reported to CMS, 2019-2025
24 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $577 · 2022: $63.74 · 2023: $108 · 2024: $444 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $173.59 | 2024 | Hydrofera Blue |
| Kerecis Limited | $144.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $104.40 | 2021 | |
| Novo Nordisk INC | $102.66 | 2021-2022 | |
| Smith+Nephew, INC. | $101.18 | 2023-2024 | Collagenase Santyl, Regranex, Grafix Pl |
| Convatec INC. | $98.09 | 2024 | |
| Reprise Biomedical, INC. | $79.50 | 2024 | Miro3d |
| Merck Sharp & Dohme LLC | $75.77 | 2021 | |
| Hartmann USA, INC. | $58.46 | 2023-2025 | Zetuvit Plus 10x10 P10, Zetuvit Plus |
| Janssen Pharmaceuticals, INC | $55.37 | 2021 | |
| Abbvie INC. | $51.54 | 2021-2022 | |
| Amgen INC. | $46.78 | 2021 | |
| Amarin Pharma, INC. | $46.57 | 2021 | |
| Ets Wound Care LLC | $45.94 | 2025 | Mirragen Advanced Wound Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.96 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $43.99 | 2023 | Puraply |
| Mimedx Group, INC. | $35.84 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $28.44 | 2021 | |
| Abbott Laboratories | $18.14 | 2021 | |
| Eisai INC. | $18.02 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.83 | 2021 | |
| Solventum Corporation | $17.60 | 2024 | Activ.A.C., V.A.C. Veraflo |
| Jazz Pharmaceuticals INC. | $16.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Repp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.